Ticker | SCHW | Earnings Date | July 21, 2026 (Pre-Market) | Prepared | July 20, 2026 |
Reporting Period | Q2 2026 (Apr–Jun 2026) | Last Earnings | April 16, 2026 (Q1 2026) | Sector ETF | KBE (S&P Bank ETF) |
Key Takeaway: The setup into Q2 2026 is constructive — consensus has moved materially higher since the Q1 print, management's May Investor Day scenario pointed to ~$1.50 EPS for the quarter, and the macro backdrop (no rate cuts, record trading volumes, strong asset flows at peers) is a tailwind — but the bar is now meaningfully elevated and the stock has already rallied ~11% since last earnings, leaving little room for disappointment on NIM or NNA.
Heading into Q2 2026 earnings, Schwab's setup is arguably the strongest it has been in several years, with every major revenue driver — net interest income, trading, asset management fees, and lending — trending above the prior-year period. Management's May 14 Investor Day explicitly guided Q2 EPS to "around the $1.50 level," implying ~5% upside to the $1.43 Q1 record, and the current consensus of ~$1.55 sits modestly above that scenario, suggesting the Street has already baked in some outperformance. The rate backdrop has shifted favorably — the market is now pricing zero cuts versus the two cuts assumed in January — which directly lifts NIM toward the guided 3.00%–3.10% full-year range and supports sequential NII expansion. Peer commentary from JPMorgan, Morgan Stanley, Goldman Sachs, and BlackRock all confirm a record-level Q2 environment for client activity, trading volumes, asset flows, and wealth management, providing strong read-through support for Schwab's NNA and fee revenue lines. The stock has re-rated from ~$92 at the Q1 print to ~$102 today, with multiple expansion accounting for a meaningful portion of the move, so the stock is not cheap heading in. The key wildcard is client cash sweep behavior: any sign that transactional sweep balances declined more than seasonal tax-payment norms in April, or that competitive pressure from JPMorgan's Smart Cash tool is accelerating cash migration, could rattle NIM expectations and reprise the post-Q1 sell-off dynamic despite a headline beat.
Key Takeaway: Consensus has moved sharply higher since the Q1 print across all key metrics, with Q2 EPS consensus of ~$1.55 sitting above management's own $1.50 scenario — the bar is elevated. NIM and Core NNA are the two biggest swing factors: NIM trajectory determines whether the NII beat is durable, while NNA momentum (consensus at ~$108B) will signal whether the 5% organic growth target is on track.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance (May 14 Investor Day) | Consensus vs. Guidance |
Adj. EPS (Diluted Operating) | $1.43 | $1.14 | $1.55 | +36% YoY | ~$1.50 (scenario) | +3.3% above guidance |
Total Revenue | $6.48B | $5.85B | $6.91B | +18% YoY | +16% to +17% YoY | ~+1% above guidance midpoint |
Net Interest Revenue | $3.14B | $2.82B | $3.31B | +17% YoY | NIM 3.00%–3.10% FY avg. | Tracking above FY midpoint |
Net Interest Margin (NIM) | 2.88% | 2.68% | 2.98% | +30 bps YoY | 3.00%–3.10% FY; 3.25%–3.30% in 4Q | ~2 bps below FY low end |
Core Net New Assets (NNA) | $140.0B ($157.5B ex-deconversion) | $80.3B | $108.3B | +35% YoY | ~5% organic growth rate | Tracking at/above 5% target |
Daily Avg. Trades / DARTs | 9.90M (record) | 7.57M | 11.01M | +45% YoY | 8.7M FY avg. (scenario) | +26% above FY scenario |
Total Client Assets | $11.77T | $10.76T | $12.97T | +21% YoY | N/A (not guided explicitly) | N/A |
Sources: Visible Alpha Consensus and Actuals Data; SCHW Q1 2026 Earnings Release (April 16, 2026); SCHW Institutional Investor Day (May 14, 2026).
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $1.43 | $1.40 | +2.2% | Beat |
Q4 2025 | $1.39 | $1.40 | -0.7% | In-Line / Slight Miss |
Q3 2025 | $1.31 | $1.25 | +4.8% | Beat |
Q2 2025 | $1.14 | $1.10 | +3.6% | Beat |
Q1 2025 | $1.04 | $1.01 | +3.0% | Beat |
Q4 2024 | $1.01 | $0.92 | +9.8% | Beat |
Q3 2024 | $0.77 | $0.75 | +2.7% | Beat |
Q2 2024 | N/A — pre-8Q window | N/A | N/A | N/A |
Quarter | Reported | Consensus | Surprise (bps) | Result |
Q1 2026 | 2.88% | 2.93% | -5 bps | Slight Miss |
Q4 2025 | 2.90% | 2.91% | -1 bp | In-Line |
Q3 2025 | 2.90% | 2.83% | +7 bps | Beat |
Q2 2025 | 2.68% | 2.62% | +6 bps | Beat |
Q1 2025 | 2.53% | 2.49% | +4 bps | Beat |
Q4 2024 | 2.36% | 2.29% | +7 bps | Beat |
Q3 2024 | 2.11% | 2.11% | 0 bps | In-Line |
Q2 2024 | N/A — pre-8Q window | N/A | N/A | N/A |
Pattern: SCHW has beaten or matched adjusted EPS consensus in 6 of the last 7 reported quarters, with beats typically in the +2% to +10% range; NIM has beaten or matched in 5 of 7 quarters, with the only meaningful miss in Q1 2026 (-5 bps) driven by client cash seasonality. The consistent beat cadence on EPS sets a high bar for Q2 2026, where consensus already sits above management's own scenario.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management materially upgraded its full-year and Q2 outlook at the May 14 Investor Day, raising revenue growth guidance to 14%–15% (from 9.5%–10.5%) and explicitly pointing to ~$1.50 Q2 EPS — the most concrete forward guidance Schwab has provided in recent memory. Tone has shifted decisively from cautious to confident, with the rate backdrop, record trading, and lending growth all cited as tailwinds.
Metric | Initial Guidance (Q1 2026 Earnings Call — Apr 16, 2026) | Revised Guidance (May 14 Investor Day) | Current Consensus | Note |
Q2 2026 EPS | Tracking above $5.70–$5.80 FY range; no explicit Q2 figure | ~$1.50 (scenario) | $1.55 | ↑ Raised at Investor Day May 14; first explicit Q2 EPS scenario; consensus sits 3% above |
Q2 2026 Revenue Growth (YoY) | Not explicitly guided for Q2 at Q1 earnings | +16% to +17% YoY | +18% YoY implied by $6.91B consensus | ↑ Raised at Investor Day May 14; consensus tracking ~1 pt above guidance midpoint |
Q2 2026 Expense Growth (YoY) | Not explicitly guided for Q2 at Q1 earnings | +10.5% to +11.5% YoY (incl. Forge + SEC 31 fee return) | N/A — not separately tracked in VA | Investor Day May 14; SEC 31 fee reinstatement adds ~50–75 bps to expense growth |
FY 2026 Revenue Growth | +9.5% to +10.5% YoY (Jan scenario, 2 rate cuts assumed) | +14% to +15% YoY (no rate cuts assumed) | +14.8% YoY implied by $27.64B consensus | ↑ Significantly raised at Investor Day May 14; consensus at top of revised range |
FY 2026 NIM | Not explicitly guided at Q1 earnings; upward momentum signaled | 3.00%–3.10% FY avg.; 3.25%–3.30% in Q4 | 3.05% FY consensus | ↑ Raised at Investor Day May 14; consensus at midpoint of range |
FY 2026 Core NNA Organic Growth | ~5% annualized; March record NNA cited as evidence | ~5% organic growth rate maintained | $568.9B FY consensus (~5% implied) | Unchanged; management confident in 5% target |
FY 2026 DATs | Record 9.9M in Q1; revenue per trade pressured by smaller positions | 8.7M FY avg. (scenario); April SMART report showed >10M | 9.88M FY consensus | ↑ Raised at Investor Day May 14; consensus well above scenario; Q2 consensus at 11.0M |
Capital Return | 19% dividend increase; $2.4B buyback in Q1; preferred redemption evaluation ongoing | ~$15B returned since end-2024; continued buyback flexibility | N/A | Investor Day May 14; tone more confident on capital return capacity |
Sources: SCHW Q1 2026 Earnings Call Transcript (April 16, 2026); SCHW Institutional Investor Day Transcript (May 14, 2026).
Key Takeaway: Estimates have moved sharply higher since the Q1 print across all key metrics, with Q2 EPS consensus up ~5% and FY 2026 EPS up ~5% from the post-Q1 baseline. Revisions are tracking with — and in some cases above — management's upgraded guidance, which is a positive signal but also means the cushion between guidance and consensus is thin, particularly on NIM and revenue.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of Apr 23, 2026) | Current Consensus (Jul 20, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance (May 14 Investor Day) | Guidance Δ | Consensus vs. Current Guidance |
Adj. EPS — Q2 2026 | $1.471 | $1.550 | +5.4% | Tracking above $5.70–$5.80 FY | ~$1.50 (scenario) | ↑ Raised | +3.3% above |
Adj. EPS — FY 2026 | $6.025 | $6.305 | +4.6% | $5.70–$5.80 (Jan scenario, excl. buybacks/Forge) | Mid-teen EPS growth through cycle; ~$6.30+ implied | ↑ Raised | Consensus at top of implied range |
Total Revenue — Q2 2026 | $6.592B | $6.905B | +4.7% | Not explicitly guided | +16% to +17% YoY | ↑ Raised | ~+1% above guidance midpoint |
Total Revenue — FY 2026 | $26.711B | $27.641B | +3.5% | +9.5% to +10.5% YoY (Jan) | +14% to +15% YoY | ↑ Significantly raised | At top of revised range |
Net Interest Revenue — Q2 2026 | $3.191B | $3.310B | +3.7% | Upward NIM momentum signaled | NIM 3.00%–3.10% FY avg. | ↑ Raised | Tracking within guided range |
NIM — Q2 2026 | 2.918% | 2.982% | +6 bps | Upward momentum; no explicit Q2 NIM guide | 3.00%–3.10% FY; 3.25%–3.30% in Q4 | ↑ Raised | ~2 bps below FY low end; sequential expansion expected |
Core NNA — Q2 2026 | $102.2B | $108.3B | +6.0% | ~5% organic growth rate | ~5% organic growth rate maintained | Unchanged | Tracking at/above 5% target |
DARTs — Q2 2026 | 8.709M | 11.008M | +26.4% | Record 9.9M in Q1; revenue per trade pressured | 8.7M FY avg. (scenario); April SMART >10M | ↑ Raised | +26% above FY scenario; peer data confirms elevated volumes |
Estimate revisions since the Q1 print have been uniformly positive and broad-based, with the largest moves in DARTs (+26%) and EPS (+5%), both tracking well above management's conservative scenario assumptions. The gap between consensus and guidance is thin on revenue and NIM, meaning any shortfall in client cash behavior or trading revenue per trade could flip the narrative quickly despite headline beats.
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of April 23, 2026 (5 trading days after April 16, 2026 earnings).
Key Takeaway: SCHW has rallied ~10.7% since the Q1 earnings date (April 16, 2026 close: $92.62 → July 21 pre-market: ~$102.54), outperforming both KBE (+10.1%) and the S&P 500 (+5.7%) over the same period. The move has been driven by a combination of estimate revisions (EPS up ~5%) and modest multiple re-rating, with the stock now trading at ~14.5x NTM P/E — not stretched but not cheap, leaving the stock dependent on continued earnings delivery.
The chart below shows SCHW, KBE (S&P Bank ETF), and SPY indexed to 100 at the April 16, 2026 Q1 earnings date. Key events are marked.
[Image not found: gs://lum-production-user-data-store/conversations/conv_01k7aqhqhbfhkbhqhbhqhbhqhb/plotly_charts/schw_stock_performance.json]
SCHW vs. KBE vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (April 16, 2026). Source: Yahoo Finance / Stock Price Data.
Ticker | Apr 16, 2026 Close | Jul 21, 2026 (Latest) | Return Since Q1 Earnings |
SCHW | $92.62 | $102.54 | +10.7% |
KBE (S&P Bank ETF) | $63.11 | $69.49 | +10.1% |
SPY (S&P 500) | $701.66 | $742.09 | +5.7% |
Key Events Since Q1 Earnings:
Source: Stock Price Data (Yahoo Finance). NTM P/E and performance decomposition from internal analytics.
Key Takeaway: Peer commentary from Q2 2026 earnings calls and conferences is uniformly bullish for Schwab's Q2 setup — record trading volumes, record asset flows, strong NII/NIM, and robust wealth management activity all read through positively. The one nuance: JPMorgan flagged that Q2 equities activity may be hard to repeat, and Robinhood noted crypto take rates declined ~7–8 bps QoQ, which could temper trading revenue per trade expectations.
Note: Only commentary describing Q2 2026 (April–June 2026) conditions or forward-looking statements made after peers' own prior-quarter earnings is included below. Retrospective commentary solely about Q1 2026 or earlier results is excluded.
Read-Through Relevance: High. JPM is the largest U.S. bank and a direct read-through on retail client activity, trading volumes, NII/NIM, and deposit behavior.
Read-Through Relevance: High. MS is the closest wealth management peer and a direct read-through on NNA, fee-based flows, NII, and retail engagement.
Read-Through Relevance: Moderate-High. GS is a read-through on institutional client activity, trading volumes, alternatives demand, and the AI/IPO cycle.
Read-Through Relevance: Moderate. BLK is a read-through on ETF flows, wealth management platform dynamics, and the ETF monetization debate directly relevant to SCHW's announced ETF fee strategy.
Read-Through Relevance: Moderate. HOOD is a direct retail trading peer and a read-through on Q2 trading volumes, crypto activity, and competitive dynamics in the retail brokerage space.
Peer | Event / Date | Key Q2 2026 Read-Through for SCHW | Direction |
JPM | Q2 Earnings, Jul 14 | Equities +86% YoY; NII beat on sweep balances; deposits +3% YoY; Smart Cash tool in testing | Mostly ↑ |
MS | Q2 Earnings, Jul 15 | Record NNA $148B; NII beat on sweep balances; transactional revenue +20% YoY; loan growth strong | ↑↑ |
GS | Q2 Earnings, Jul 14 | Record equities $7.4B; alternatives fundraising record $59B; IB backlog 5-year high; wealth AUM record $2T | ↑↑ |
BLK | Q2 Earnings, Jul 15 | ETF inflows $178B; BLK resists index ETF tolls (limits SCHW monetization scope); cash AUM +10% YoY | Mixed |
HOOD | Bernstein Conf., May 27; Piper Sandler Conf., Jun 4 | Q2 trading volumes record; crypto take rate -7-8 bps QoQ; PDT rule removal modest competitive risk; margin book record | Mostly ↑ |
Key Takeaway: The most important development since Q1 earnings was the May 14 Investor Day, where management raised guidance materially and launched crypto to first clients — both of which have been net positives for the stock. The June debt issuance is balance sheet management, not a signal of stress.
Key Takeaway: The standout transaction is CEO Rick Wurster's discretionary open-market purchase of ~$1.87M on May 28 — a meaningful bullish signal at a price ~17% below current levels. The Schwab family's ongoing sales are large in absolute terms but appear to be part of a long-running estate/trust distribution program and should not be read as a negative signal. 10b5-1 plan sales by MDs are routine.
Name | Title | Transaction Type | Shares | Approx. Value | Transaction Date | Disclosure Date | Note |
Wurster, Richard A. | President & CEO, Director | Open Market Buy | 21,959 | ~$1.87M | May 28, 2026 | May 28, 2026 | Discretionary; NOT a 10b5-1 plan. Purchased at ~$85.35. Significant bullish signal from CEO. |
Schwab, Charles R. | Co-Chairman, Director | Open Market Sale | 27,500 | ~$2.3M | May 19, 2026 | May 20, 2026 | Sold via Limited Partnership (indirect). Part of ongoing estate/trust distribution program; not a 10b5-1 plan per filing. |
Schwab, Charles R. | Co-Chairman, Director | Open Market Sale | 109,300 + 109,300 | ~$18.6M | May 4–6, 2026 | May 6, 2026 | Sold via Limited Partnership (indirect). Large in absolute terms; consistent with long-running estate distribution pattern. |
Schwab, Charles R. | Co-Chairman, Director | Open Market Sale | 50,000 + 55,000 + 63,743 | ~$14.5M | Apr 29 – May 1, 2026 | May 1, 2026 | Sold via Trust (indirect). Ongoing estate/trust distribution; not flagged as 10b5-1. |
Schwab, Charles R. | Co-Chairman, Director | Open Market Sale | 36,450 + 36,450 | ~$6.6M | Apr 23–27, 2026 | Apr 27, 2026 | Sold via Trust (indirect). Ongoing estate/trust distribution. |
Schwab-Pomerantz, Carolyn | Director | Open Market Sale | 9,910 | ~$0.9M | May 5, 2026 | May 6, 2026 | Sold via Trust (indirect). Schwab family member; consistent with estate distribution pattern. |
Sarin, Arun | Director | Open Market Sale | 2,500 | ~$0.2M | May 13, 2026 | May 14, 2026 | Sold via Trust (indirect). Small discretionary sale by independent director. |
Herringer, Frank C. | Director | Open Market Sale | 2,520 | ~$0.2M | Apr 28, 2026 | Apr 29, 2026 | Sold via Trust (indirect). Small discretionary sale by independent director. |
Craig, Jonathan M. | MD, Head of Retail Investing | 10b5-1 Planned Sale | 21,750 | ~$2.2M | Jul 7, 2026 | Jul 9, 2026 | Pre-planned 10b5-1 sale via Trust. Routine; not discretionary. |
Beatty, Jonathan S. | MD, Head of Advisor Services | 10b5-1 Planned Sale | 2,000 + 2,000 + 2,000 | ~$0.6M | Jul 2–7, 2026 | Jul 6–8, 2026 | Pre-planned 10b5-1 sales via Trust. Routine; not discretionary. |
Woolway, Paul V. | MD, Chief Banking Officer | 10b5-1 Planned Sale | 7,941 + 7,942 | ~$1.5M | Apr 14–15, 2026 | Apr 16, 2026 | Pre-planned 10b5-1 sales via Trust. Routine; not discretionary. |
Source: SEC Form 4 Filings Database (Insider Transaction Data).